- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: HER2 Overexpression
Total 2840 results
-
AstraZenecaMerck Sharp & Dohme LLC; NRG Oncology; Breast International Group; Myriad Genetic... and other collaboratorsActive, not recruitingBreast CancerUnited States, Austria, Italy, Spain, Sweden, United Kingdom, Belgium, Poland, France, Switzerland, Canada, Germany, Korea, Republic of, Netherlands, Japan, China, Taiwan, Australia, Argentina, Israel, Hungary, Portugal, Iceland, Puerto...
-
Daiichi SankyoAstraZenecaCompletedAdenocarcinoma Gastric Stage IV With Metastases | Adenocarcinoma - GEJUnited States, Spain, Belgium, Italy, United Kingdom
-
Tomsk National Research Medical Center of the Russian...Uppsala UniversityCompletedBreast Cancer FemaleRussian Federation
-
Spectrum Pharmaceuticals, IncSuspended
-
Daiichi Sankyo Co., Ltd.AstraZeneca; Daiichi Sankyo, Inc.CompletedAdvanced Solid TumorsUnited States, Japan
-
Daiichi Sankyo Co., Ltd.AstraZenecaCompletedNeoplasm MetastasisKorea, Republic of, Taiwan, Japan
-
UNICANCERDaiichi Sankyo Europe, GmbH, a Daiichi Sankyo CompanyActive, not recruiting
-
Jazz PharmaceuticalsActive, not recruitingHER2+/HR+ Breast CancerUnited States, Spain, Canada
-
Seagen Inc.National Cancer Institute (NCI); Academic and Community Cancer Research UnitedCompletedMetastatic Colorectal AdenocarcinomaUnited States, Spain, Belgium, France, Italy
-
Armando GiulianoWithdrawnBreast Cancer | HER2-positive Breast CancerUnited States
-
Silverback TherapeuticsTerminatedHER2-positive Breast Cancer | HER2-positive Gastric Cancer | HER2-positive Colorectal Cancer | HER2-expressing Non-small Cell Lung CancerUnited States
-
Memorial Sloan Kettering Cancer CenterCompleted
-
Daiichi Sankyo Co., Ltd.AstraZenecaCompletedMalignant Neoplasm of BreastJapan
-
Sihuan Pharmaceutical Holdings Group Ltd.Covance; XuanZhu Pharma Co., Ltd.CompletedAdvanced Solid TumorsUnited States
-
Michael Morse, MDGlaxoSmithKlineCompletedMetastatic Breast CancerUnited States
-
Baylor Breast Care CenterGlaxoSmithKlineCompleted
-
Ichnos Sciences SAGlenmark Pharmaceuticals S.A.TerminatedBreast CancerUnited States
-
Puma Biotechnology, Inc.TerminatedMetastatic Cervical Cancer | Hormone Receptor-Positive, HER2-Negative Metastatic Breast CancerSpain, Israel, United States, Serbia, France, Ireland, Italy
-
Memorial Sloan Kettering Cancer CenterUniversity of Michigan; Queens Cancer Center of Queens HospitalCompletedMetastatic Breast Cancer | Central Nervous System (CNS) MetastasesUnited States
-
Dorte NielsenTerminated
-
Dartmouth-Hitchcock Medical CenterCompleted
-
Genentech, Inc.Hoffmann-La RocheCompletedMetastatic Breast CancerUnited States, Canada, China, Finland, France, Germany, Hong Kong, Italy, Korea, Republic of, Spain, United Kingdom, Brazil, Guatemala, Japan, Russian Federation, Singapore, Thailand, Latvia, Argentina, Poland, Ecuador, Mexico, Croatia and more
-
Novartis PharmaceuticalsTerminatedCancerCzechia, Poland, Russian Federation, United Kingdom, Israel
-
Shanghai Changzheng HospitalUnknown
-
Puma Biotechnology, Inc.CompletedBreast CancerSpain, China, United States, Australia, Hong Kong, Malaysia, Korea, Republic of, Singapore, Belgium, Japan, India, France, Hungary, Romania, Italy, Bulgaria, Germany, Serbia, United Kingdom, South Africa, Canada, Israel, Taiwan, Switz... and more
-
University of Kansas Medical CenterCelgene CorporationCompleted
-
Genentech, Inc.Completed
-
Shanghai Zhongshan HospitalCompleted
-
Merrimack PharmaceuticalsTerminatedBreast Cancer | HER2 Positive Breast CancerSpain, United States, Italy, France, Canada, Belgium, Austria, Germany, Czech Republic
-
Translational Oncology Research InternationalGenentech, Inc.Completed
-
Azienda Ospedaliera Ordine Mauriziano di TorinoUnknownMetastatic Breast CancerItaly
-
University of Maryland, BaltimoreWithdrawnBreast Cancer With Brain MetastasisUnited States
-
Pieris Pharmaceuticals, Inc.CompletedHER2-positive Breast Cancer | HER2-positive Gastric Cancer | HER2-positive Bladder Cancer | HER2-positive Solid TumorUnited States
-
Mersana TherapeuticsRecruitingHER2-positive Breast Cancer | HER2-positive Gastric Cancer | HER2-positive Non-Small Cell Lung Cancer | HER2-positive Colorectal Cancer | HER2-positive Tumors | HER2 Low Breast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedHER2-positive Carcinoma | HER2-positive Primary MalignancyUnited States
-
Thomas HatschekActive, not recruitingEarly-Stage Breast Carcinoma | HER-2 Positive Breast CancerSweden
-
Bavarian NordicCompletedBreast CancerUnited States
-
Orum Therapeutics USA, Inc.RecruitingHER2-positive Breast Cancer | HER-2 Gene Amplification | HER2 Gene Mutation | HER-2 Protein OverexpressionUnited States
-
Peking Union Medical College HospitalCompleted
-
First Affiliated Hospital Bengbu Medical CollegeRecruitingAdenocarcinoma of the Stomach | Adenocarcinoma - GEJChina
-
Bavarian NordicCompletedBreast CancerUnited States
-
Beijing 302 HospitalRecruiting
-
ABSCINT NV/SANot yet recruiting
-
BayerRecruitingHealthy Volunteers | Advanced Non-small Cell Lung Cancer | EGFR Mutation | HER2 MutationUnited Kingdom
-
China Medical University, ChinaShanghai First Song Therapeutics Co., LtdRecruiting
-
Seattle Children's HospitalRecruitingDiffuse Intrinsic Pontine Glioma | Diffuse Midline Glioma | Refractory Primary Malignant Central Nervous System Neoplasm | Recurrent CNS Tumor, Adult | Recurrent, CNS Tumor, ChildhoodUnited States
-
Peking Union Medical College HospitalRecruiting
-
Tongji HospitalRecruiting
-
Shanghai Miracogen Inc.RecruitingAdvanced Malignant Solid TumorsChina
-
Shanghai Miracogen Inc.Not yet recruitingNon-small- Cell Lung Cancer (NSCLC)China